歷年活動 Events

2018 Antibody Therapeutics Conference

間:2018.12.04 (二) 09:00 - 17:30 (GMT+8)

點:國家生技研究園區 C棟國際會議廳 (台北市南港區研究院路一段130巷99號)

Time Topic and Speaker
08:30 - 09:00 Registration
09:00 - 09:05 Opening Remarks
Lawrence Gan, Ph.D
Director of Taiwan Antibody Association; President/CEO, Foresee Pharmaceuticals
09:05 - 09:10 Herbert Wu, Ph.D.
President, Development Center for Biotechnology
Opening Keynote
09:10 - 09:15 Moderator:Andrew H.-J. Wang, Ph.D.
Distinguished Visiting Chair, Institute of Biological Chemistry, Academia Sinica; President, IUBMB
09:15 - 10:00 Cancer Cell Cast a Sweet Spell on Tumor Microenvironment: Opportunities and Challenges
Alice Yu, M.D., Ph.D.
Distinguished Professor & Co-Director of the Institute of Stem Cell & Cancer Translational Research in Chang Gung Memorial Hospital
10:00 - 10:30 Break
10:30 - 10:35 Moderator:Shie-Liang Edmond Hsieh, M.D., D.Phil.
Distinguished Research Fellow, Genomics Research Center, Academia Sinica
10:35 - 11:05 What You Eat Makes You Strong but Vulnerable : Metabolic Targeting of Intramural Tregs in Cancer Immunotherapy
Ping-Chih Ho, Ph.D.
Assistant Professor/Ludwig adjunct scientist, UNIL CHUV/Ludwig Institute for Cancer Research Lausanne
11:35 - 12:05 Finding Better Combinations of Immunotherapy
Keng-Li Lan, M.D., Ph.D.
Associate Professor, National Yang-Ming University; Taipei Veterans General Hospital
12:05 - 13:40 Lunch
(Taiwan Antibody Association Members Meeting and Poster Viewing)
12:15 - 12:45 Lunch Panel / Industry satellite symposium
13:40 - 13:45 Moderator:Ping-Ning Hsu, M.D., Ph.D.
Professor, Graduate Institute of Immunology, National Taiwan University
13:45 - 14:15 Understanding Immune Checkpoint TIM-3 Biology and TIM-3 Antibody for Cancer Immunotherapy
Xiaomo Jiang , Ph.D.
Investigator II, Novartis Institutes for Biomedical Research
14:15 - 14:45 Clinical Experience and Safety Management of Immunotherapy
John Wen-Cheng Chang, M.D.
Chairman, Taiwan Society for Immunotherapy of Cancer
14:45 - 15:15 Current Progress of Immunotherapy for Non-small Cell Lung Cancer
Chih-Hsin Yang, M.D., Ph.D.
Professor & Director, Graduate Institute of Oncology, National Taiwan University
15:15 - 15:45 Break
15:45 - 16:00 Poster Award
Closing Keynote
16:00 - 16:05 Moderator:Herbert Wu, Ph.D.
President, Development Center for Biotechnology
16:05 - 16:50 Engineering Adaptive Cell and Gene Therapies
Timothy K. Lu, Ph.D.
Associate Professor, Massachusetts Institute of Technology (MIT)
16:50 - 17:00 Closing Remarks
Herbert Wu, Ph.D.
President, Development Center for Biotechnology